
USFDA APPLICATION NUMBER - 21184 / DOSAGE - CREAM;TOPICAL - 0.1%
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| tazarotene(UNII: 81BDR9Y8PS) (tazarotene - UNII:81BDR9Y8PS) | tazarotene | 1mg in 1 | 0.5mg in 1 |
Inactive Ingredients
| Ingredient Name | Allergan, Inc. | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
|---|---|---|
| Benzyl alcohol(LKG8494WBH) | ||
| CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES(U72Q2I8C85) | ||
| carbomer 1342(809Y72KV36) | ||
| CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)(809Y72KV36) | ||
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)(HHT01ZNK31) | ||
| edetate disodium(7FLD91C86K) | ||
| GLYCERYL CAPRYLOCAPRATE(U72Q2I8C85) | ||
| MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U) | ||
| mineral oil(T5L8T28FGP) | ||
| sodium hydroxide(55X04QC32I) | ||
| sodium thiosulfate(HX1032V43M) | ||
| sorbitan monooleate(06XEA2VD56) | ||
| water(059QF0KO0R) |